Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study

BACKGROUND: A third-generation coronary drug-eluting resorbable magnesium scaffold (DREAMS 3G) was developed to enhance the performance of previous scaffold generations and achieve angiographic outcomes comparable to those of contemporary drug-eluting stents. METHODS: This prospective, multicenter,...

Descripción completa

Detalles Bibliográficos
Autores principales: Haude, Michael, Wlodarczak, Adrian, van der Schaaf, René J., Torzewski, Jan, Ferdinande, Bert, Escaned, Javier, Iglesias, Juan F., Bennett, Johan, Toth, Gabor, Joner, Michael, Toelg, Ralph, Wiemer, Marcus, Olivecrona, Göran, Vermeersch, Paul, Garcia-Garcia, Hector M., Waksman, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126775/
https://www.ncbi.nlm.nih.gov/pubmed/37113674
http://dx.doi.org/10.1016/j.eclinm.2023.101940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126775/
https://www.ncbi.nlm.nih.gov/pubmed/37113674
http://dx.doi.org/10.1016/j.eclinm.2023.101940

Ejemplares similares